Caraco Denied Quick Win On Prandin IP Misuse Claim
By Abigail Rubenstein · February 25, 2011, 3:08 PM EST
A federal judge in Michigan on Thursday refused to analyze Caraco Pharmaceutical Laboratories Ltd.'s contention that Novo Nordisk A/S misused its patent for the diabetes drug Prandin, finding the matter inappropriate...
To view the full article, register now.